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ALI = acute lung injury; ARDS = acute respiratory distress syndrome; BAL = bronchoalveolar lavage; CXCL = CXC chemokine ligand; CXCR =
CXC chemokine receptor; ENA = epithelial neutrophil-activating peptide; fMLP = N-formylmethionyl-leucyl-phenylalanine; GAG = glycosamino-
glycan; ICAM = intercellular adhesion molecule; IL = interleukin; KC = keratinocyte-derived chemokine; LPS = lipopolysaccharide; MIP =
macrophage inflammatory protein; PECAM = platelet endothelial cell adhesion molecule; PMN = polymorphonuclear leukocyte; TF = tissue factor;
TFPI = tissue factor pathway inhibitor; TNF = tumor necrosis factor; VCAM = vascular cell adhesion molecule.
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Introduction
Acute lung injury (ALI) and acute respiratory distress
syndrome (ARDS) are characterized by increased permeability
of the alveolar–capillary barrier, resulting in influx of protein-
rich edema fluid and consequently impairment in arterial
oxygenation. Although mortality has decreased over recent
decades, it remains high (30–40%), and pulmonary and
nonpulmonary morbidity in ARDS survivors is significant [1].
Although ALI has been described in neutropenic patients,
activation and transmigration of circulating neutrophils
(polymorphonuclear leukocytes [PMNs]) are thought to play a
major role in the early development of ALI [2]. In most animal
models, elimination of PMNs markedly decreases the severity
of ALI [3]. In addition, recovery from neutropenia in some
patients with lung injury is associated with a deterioration in
pulmonary function [4].
Various animal models have been developed to study the
molecular basis of PMN trafficking in the lung (Table 1), but
each mimics only some aspects of the clinical situation. Pre-
existing pulmonary or nonpulmonary diseases, fluid
resuscitation, and mechanical ventilation significantly
influence the course of ALI but are not considered in most
animal models. In addition, experimental methods with which
to study PMN recruitment are limited; for example, intravital
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Abstract
Acute lung injury and its more severe form, acute respiratory distress syndrome, are major challenges
in critically ill patients. Activation of circulating neutrophils and transmigration into the alveolar airspace
are associated with development of acute lung injury, and inhibitors of neutrophil recruitment attenuate
lung damage in many experimental models. The molecular mechanisms of neutrophil recruitment in the
lung differ fundamentally from those in other tissues. Distinct signals appear to regulate neutrophil
passage from the intravascular into the interstitial and alveolar compartments. Entry into the alveolar
compartment is under the control of CXC chemokine receptor (CXCR)2 and its ligands (CXC
chemokine ligand [CXCL]1–8). The mechanisms that govern neutrophil sequestration into the vascular
compartment of the lung involve changes in the actin cytoskeleton and adhesion molecules, including
selectins, β2 integrins and intercellular adhesion molecule-1. The mechanisms of neutrophil entry into
the lung interstitial space are currently unknown. This review summarizes mechanisms of neutrophil
trafficking in the inflamed lung and their relevance to lung injury.
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microscopy has produced great insight into leukocyte–
endothelial interactions in many organs, but it is still
technically challenging in the lung.
The specific architecture of the lung leads to unique properties
of the pulmonary microcirculation. Even under physiologic
conditions, neutrophils must stop several times and change
their shape to traverse the small pulmonary capillaries
(2–15 µm [5]). This leads to an increased transit time through
the pulmonary capillary bed and a significant 40- to 100-fold
PMN accumulation (‘marginated pool’) in the lungs (Fig. 1) [6].
In the systemic microcirculation, PMN recruitment from blood
into tissue at sites of inflammation usually occurs in post-
capillary venules and requires capture, rolling, and firm
adhesion on activated endothelial cells. Selectin, integrin and
immunoglobulin adhesion molecules, cytokines, chemokines,
and other chemoattractants participate in this sequential
process in a variety of vascular beds [7–9]. In contrast, the
principal site of leukocyte migration in the lung is the capillary
bed. PMN migration into the different lung compartments
(intravascular, interstitial, and intra-alveolar) is differentially
regulated because PMNs can enter the pulmonary
interstitium without advancing to the alveolar airspace.
However, crossing the epithelial barrier seems to be pivotal
for inducing lung damage and it is associated with an
increase in mortality [10]. Bacterial endotoxin (lipopoly-
saccharide [LPS]) is known to induce a large influx of PMNs
into the alveolar airspace, but only when it is given
intratracheally. In contrast, systemic LPS leads to PMN
sequestration in the pulmonary vasculature, but most of these
cells never appear in bronchoalveolar lavage (BAL) fluid [11].
This review summarizes experimental findings that provide
insight into the mechanisms of PMN recruitment in the
pulmonary microvasculature, including the migration steps
from blood to alveolar airspace. The interrelation between
lung inflammation and coagulation provides a target for
potential future pharmacological interventions, and we
critically discuss the clinical relevance of these experimental
findings.
Sequestration of neutrophils in the inflamed
lung
In contrast to physiologic margination, neutrophil sequestra-
tion reflects the process of neutrophil accumulation in the
pulmonary vasculature in response to an inflammatory
stimulus. Inflammatory challenge results in a rapid depression
in circulating neutrophils in the blood, mainly due to a
dramatic increase in PMN sequestration in the pulmonary
microvasculature. Altered biomechanical properties of neutro-
phils are thought to be important for PMN sequestration in
the lung in response to various mediators such as tumor
necrosis factor (TNF)-α, IL-8, platelet-activating factor, and N-
formylmethionyl-leucyl-phenylalanine (fMLP) [12,13]. Activated
neutrophils lose their ability to deform mainly because of
intracellular polymerization of actin filaments. Actin filaments
are redistributed from the central, perinuclear regions to the
peripheral regions in response to chemoattractants, forming
actin stress fibers, lamellipodia, ruffles, and filopodia. As a
result of these changes in cell shape in response to a
chemoattractant, transit time through the pulmonary
vasculature is prolonged, resulting in an increased
concentration of PMNs [14]. Inhibition of cellular actin
organization with cytochalasin D prevents fMLP-induced
Table 1
Common animal models of acute lung injury
Current Clinical 
Model knowledge Reproducibility relevance Concerns
LPS (iv or ip) +++ +++ +++ Different LPS strains with variable biologic effects; mimics bacterial 
effects only in part
LPS (intratracheal) +++ +++ +++ Heterogeneous distribution in the lung; might not reach small 
bronchi or alveoli; might also result in aspiration injury
LPS (aerosolized) ++ ++ +++ Effective dosage difficult to control
Live bacteria (systemic  +++ +++ +++ Supportive therapy needed (fluid resuscitation; antibiotics)
or intratracheal)
Cecal ligation and puncture ++ + +++ Supportive therapy needed; standardized intervention difficult
Acid aspiration +++ +++ ++ Different models of installation the acid (whole lung versus focal); 
requirement for anesthesia
Ischemia/reperfusion + ++ ++ Technically challenging; different models (in vivo, ex vivo, with or 
without bronchus ligation, with or without mechanical ventilation)
Others* + ++ + Not yet systematically studied 
Shown are common animal models of acute lung injury with respect to current knowledge about the model (+ = scant, +++ = rich), reproducibility
of the insult (+ = limited, +++ = excellent), and clinical relevance (+ = limited, +++ = high). *Hemorrhage, pancreatitis, IgG complex deposition,
instillation of various chemoattractants and/or antibodies to chemoattractants. ip, intraperitoneal; iv, intravenous; LPS lipopolysaccharide.455
PMN sequestration [15]. Circulating neutrophils in ARDS
patients were found to be less deformable [16], emphasizing
the key role played by structural changes in PMN entrapment
in the lung microvasculature.
The role of adhesion molecules in this process is not clear.
L-selectin-deficient mice exhibit attenuation of prolonged
(5 min after complement injection) capillary sequestration,
whereas rapid PMN accumulation is only reduced in
noncapillary vessels [17]. L-selectin is required for the
sequestration of neutrophils in the lung in response to the
formyl peptide fMLP, but not C5a, as shown by blocking
antibodies and L-selectin-deficient mice [18]. In a model of
sepsis-induced ARDS, antibodies to E-selectin and L-selectin
did not affect PMN sequestration [19]. Deficiency in either
E-selectin and P-selectin or CD18 alone did not affect
sequestration [20]. However, blocking CD18, α4, and α5
integrin in combination resulted in a significant attenuation of
fMLP-induced sequestration into the lung. Additional
inhibition of E-selectin and L-selectin further attenuated PMN
sequestration, whereas inhibition of these selectins alone had
no effect [21]. Interestingly, these blocking antibodies did not
inhibit the physical deformation properties of PMNs,
suggesting that neutrophil deformability is not the only
regulator of sequestration.
Transendothelial migration of neutrophils
Transendothelial PMN migration in response to inflammatory
stimuli occurs in the pulmonary capillary bed, mainly by
penetrating interendothelial junctions or at bicellular or
tricellular corners of endothelial cells, although there is an
alternative, transcellular route [22]. Sequestered and
adherent neutrophils induce cytoskeletal changes in the
endothelial cells. Adhesive interactions between leukocytes
and endothelial cells, leading to intracellular signaling through
transmembrane proteins in the area of tight junctions (e.g.
platelet endothelial cell adhesion molecule [PECAM]-1,
CD99, VE-cadherin), might trigger transient remodeling of the
junction [23,24]. It has been suggested that neutrophil
proteases may digest the subendothelial matrix. However,
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Figure 1
Neutrophil trafficking in the lung. Neutrophils (polymorphonuclear leukocytes [PMNs], colored blue) enter a pulmonary capillary (left). Because of
the small diameter of the capillary, neutrophils must deform, which increases transit time (‘margination’) even under resting conditions (inset A:
margination). In venules, adhesion molecule (AM)-dependent rolling can occur. In response to an inflammatory stimulus (red arrow), neutrophils
adhere to the capillary endothelium (inset B: sequestration). AMs and chemokines (not shown) might be involved in this process. Alveolar
macrophages and type II pneumocytes produce CXC chemokines, which attract neutrophils to migrate through the endothelium (inset C1:
transendothelial migration), interstitial space, and epithelium (inset C2: transepithelial migration) to reach the alveolar space. The requirement of
AMs for the different steps is dependent on the stimulus and the used model (see text for details). Arrows indicate directions of flow, and dashed
lines indicate endothelial and epithelial basement membrane.456
inhibition of these proteases does not affect neutrophil
transendothelial migration [25] or migration through the
basement membrane [26].
Role of adhesion molecules
The initial steps of the leukocyte adhesion cascade include
capture and rolling of circulating leukocytes and require E-, L-
and P-selectin [27], whereas integrins – heterodimeric
transmembrane glycoproteins – mediate firm adhesion by
interacting with intercellular adhesion molecules (e.g.
intercellular adhesion molecule [ICAM]-1, ICAM-2, vascular cell
adhesion molecule [VCAM]-1) [28]. Selectins and β2 integrins
(CD18) are the most studied adhesion molecules in ALI.
Integrins
PMN migration in the lung can occur in both CD18-dependent
and CD18-independent pathways, depending on the stimulus
(Table 2). Neutrophil recruitment requires CD18 when
induced by Escherichia coli, Pseudomonas aeruginosa, IL-1,
or IgG immune complexes, whereas migration in response to
Gram-positive bacteria, hyperoxia, and complement factor
C5a is CD18 independent. Aspiration of hydrochloric acid
induces a CD18-independent PMN migration at the site of
instillation but CD18-dependent PMN recruitment in the
contralateral lung [29]. The way of application also influences
the CD18 dependency of PMN migration. Intratracheal
instillation of LPS leads to a CD18 dependent recruitment into
the alveolar airspace [30]. However, the same endotoxin given
intraperitoneally [20] results in a neutrophil sequestration that
is independent of CD18 and attenuates PMN recruitment in
response to intratracheal LPS [31].
Most stimuli inducing a CD18-dependent PMN migration
upregulate ICAM-1 – a major ligand for CD18 – on endo-
thelial cells. Endothelial ICAM-1 expression was increased
following  E. coli LPS, but not Streptococcus pneumoniae
challenge [32]. The fact that IL-1 and TNF-α, both of which
are nuclear factor-κB-dependent proinflammatory cytokines
that regulate expression of ICAM-1, are required for
CD18/ICAM-1-dependent pathways supports this hypo-
thesis. In addition, members of the β1 integrin family (very late
antigen-4 and -5) may mediate CD18-independent PMN
migration [22].
The CD18 integrin Mac-1 (CD11b/CD18) appears to be very
important in PMN recruitment in the lung because antibodies
to Mac-1, but not to lymphocyte function-associated
antigen-1 (LFA-1, CD11a/CD18), inhibited neutrophil migration
significantly in an inhaled LPS model [33]. Neutrophil
inhibiting factor, a hookworm-derived protein that binds to
and blocks CD11b, also prevents PMN recruitment into the
lung [34].
PECAM-1, a member of the immunoglobulin superfamily,
localizes close to interendothelial clefts and has been
suggested to regulate PMN migration in the pulmonary
vasculature. In an early study [35], antibodies to PECAM-1
attenuated neutrophil emigration into the lung in response to
IgG immune complex deposition. However, PECAM-1
expression does not change in response to inflammatory
changes [36,37], and in a more recent study [38] blocking
PECAM-1 did not prevent E. coli or S. pneumoniae induced
lung injury in rats or mice.
Selectins
Although selectins are essential for initiating the rolling
process in the systemic vasculature, their role for PMN
transmigration in the pulmonary microcirculation is less clear
and depends on the inflammatory stimulus. LPS-induced
migration into the alveolar airspace was not inhibited by
blocking all three selectins [39]. Neutrophil emigration is
unaffected by Streptococcus pneumoniae in mice lacking
E-selectin and P-selectin with L-selectin function blocked
[40]. In contrast, all selectins have been shown to participate
in the development of lung injury induced by complement or
intratracheal deposition of IgG complexes [41] or bacterial
LPS [42], suggesting that the involvement of selectins may
be stimulus-dependent. L-selectin function is necessary for
sustained intracapillary accumulation of neutrophils, but not
for emigration of neutrophils [43].
The impact of adhesion molecule mediated leukocyte–
endothelium interaction in patients with ALI is yet to be
elucidated. In lung tissue samples from patients who had died
from ARDS, a strong upregulation of ICAM-1, VCAM-1 and
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Table 2
Role of CD18 integrins for neutrophil recruitment in different
rodent and rabbit models of acute lung injury
CD18 dependency Stimulus
Dependent Escherichia coli
Pseudomonas aeruginosa
E. coli endotoxin (intratracheally administered)
Cobra venom factor
Hydrochloric acid (contralateral lung)
IgG immune complex
IL-1
Independent Streptococcus pneumoniae
Group B streptococcus
Staphylococcus aureus
E. coli endotoxin (systemically administered)
Hydrochloric acid (site of installation)
Hyperoxia
Complement protein C5a
IL, interleukin.457
E-selectin was found, suggesting that these adhesion
molecules play a role in human lung injury [36]. In an ex vivo
study [44], human PMNs were found to express higher levels
of CD18 after incubation with BAL fluid from ARDS patients
who received a conventional as opposed to a lung protective
ventilation strategy. It was suggest that this, in addition to
lower mechanical stress, could explain the beneficial effect of
mechanical ventilation using low tidal volumes [45].
Chemokines
Chemokines are a group of approximately 40 small
chemoattractant proteins (70–125 amino acids; 6–14 kDa)
that bind to G-protein coupled receptors [46]. In humans,
CXC chemokine ligand (CXCL)1–CXCL3 and CXCL5–
CXCL8 bind to CXC chemokine receptor (CXCR)1 and
CXCR2, and are potent chemotactic factors for neutrophils.
In mice, CXCL1–3, CXCL5 and CXCL6 bind to CXCR2.
CXCL1 and CXCL2 have been shown to induce rapid
integrin activation, causing arrest from rolling and chemotaxis
[47]. Chemotaxis to chemokines or other soluble
chemoattractants such as C5a, platelet-activating factor,
leukotriene B4, or fMLP might be the most important trigger
for PMN recruitment into the lung.
Chemokines are produced by activated macrophages,
monocytes, neutrophils, endothelium, epithelium, platelets,
and various parenchymal cells [48]. After having been
secreted, some chemokines are immobilized by specific
glycosaminoglycans (GAGs) on target cells. GAG-bound
chemokines may be able to activate neutrophils, or they must
first dissociate from GAGs to interact with their receptors
[49]. Neutrophils stimulated by chemokines generate a
(chemokine receptor-rich) pseudopod at the leading edge
and a tail-like uropod, allowing for a directional movement
toward the chemokine gradient [50]. Actin polymerization and
depolymerization required for this cell remodeling are
regulated by Rho, Rac, and Cdc42 proteins, which are
members of the Rho family of small G proteins [51].
Chemokines are able to activate these small G proteins and
thereby induce locomotion (Rac), unidirectional movement
(Cdc42), and uropod retraction (Rho) [49]. Lack of Rac2, the
predominant Rac isoform in human neutrophils, results in a
severe immunodeficiency with impaired neutrophil
polarization and chemotaxis [52].
The best studied CXC chemokine in humans is CXCL8 (IL-8),
which has significant relevance to lung injury. High
concentrations of IL-8 in BAL fluid from ARDS patients are
associated with increased neutrophil influx into the airspace,
and  in vitro chemotactic activity of BAL fluid can be
attenuated by removing IL-8 [53]. Intratracheal instillation of
IL-8 leads to a PMN influx in models of ALI, and blocking IL-8
has been shown to ameliorate lung damage in models of acid
aspiration [54], pancreatitis [55], and reperfusion injury [56].
Recent studies suggest that IL-8 in BAL fluid from ARDS
patients is bound to an anti-IL-8 autoantibody. This immune
complex exhibits chemotactic and proinflammatory activity
[57] and its concentration might be an important prognostic
factor for the development and outcome of ARDS [58,59].
In rodents, the two most important chemokines for PMN
recruitment into the lung are keratinocyte-derived chemokine
(KC) and macrophage inflammatory protein (MIP)-2 [46].
Both bind to and activate CXCR2, but differ in their biological
potency and affect PMN migration into the lung in different
ways [60]. Only KC is selectively transported from the lung to
the blood, whereas MIP-2 is retained in the lung compartment
[61]. Circulating KC may be able to ‘prime’ circulating PMNs
to migrate into the lung in response to MIP-2. After an
intraperitoneal LPS challenge in mice, mRNA for both KC and
MIP-2 is increased in lung tissue [62]. MIP-2 and CINC (the
rat orthologue of KC) are upregulated in a hindlimb
ischemia/reperfusion-induced lung injury model [63].
Neutralization of either chemokine significantly decreases
neutrophil recruitment into the lung [64]. Similarly, absence or
blockade of CXCR2 attenuates neutrophil influx into the lung
[65]. In a murine model of ventilator-induced lung injury,
mechanical ventilation with high peak pressures resulted in
an increase in both KC and MIP-2, and their level correlated
with lung injury and neutrophil sequestration [66].
These chemokines may be released by alveolar
macrophages, alveolar type II cells, and endothelial cells
[20,67,68]. After an intratracheal LPS challenge, both KC
and MIP-2 are found in the alveolar airspace. KC is
synthesized, secreted, and deposited on syndecan-1 (a cell-
bound proteoglycan) molecules. Matrilysin, a matrix
metalloproteinase, cleaves this KC–syndecan-1 complex and
thereby may create a chemotactic gradient. Matrilysin-
deficient mice lack the ability to create such a chemotactic
gradient, and transepithelial efflux of neutrophils is attenuated
[10]. In the setting of ALI, the p38 mitogen-activated protein
kinase pathway appears to play a major role. P38 has been
shown to stimulate the nuclear factor-κB mediated
production of various cytokines, such as IL-1β and TNF-α,
and to affect chemotaxis, adhesion and oxygen release,
particularly in neutrophils [2]. P38 is activated in neutrophils
after endotoxin exposure, and inhibition of p38 attenuates
intratracheal LPS-induced neutrophil migration into the
airspace without affecting the PMN accumulation in the lung
and, even more interesting, without affecting the alveolar
expression of chemokines KC and MIP-2 [69].
Although KC and MIP-2 are the most studied chemokines in
rodent models of ALI, other CXC chemokines might be
involved. Epithelial neutrophil-activating peptide (ENA)-78
(CXCL5) has been measured in the airspace of ARDS
patients and correlated with neutrophil counts in BAL fluid
[70], although the chemotactic potency appeared to be less
when compared with IL-8 [71]. Increased ENA-78 expression
was also found in a model of lung injury in rats induced by
hepatic ischemia/reperfusion [72]. In contrast, LPS-induced
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CXC chemokine (LIX; the murine orthologue of ENA-78)
expression in the lung was not affected in a model of
abdominal sepsis [73].
Lungkine (CXCL15) is exclusively expressed in lung epithelial
cells and is upregulated in various lung inflammation models.
In a Klebsiella pneumoniae infection model, lungkine-
deficient mice exhibited reduced PMN migration into the
alveolar space, whereas recruitment from the blood into the
lung parenchyma appeared to be unaffected, suggesting a
role for this chemokine in migration through the alveolar
epithelium [74].
Neutrophil recruitment: crosstalk between
inflammation and coagulation
More than 80 years ago, the deposition of fibrin strands in the
inflamed lung tissue was suggested to be responsible for the
emigration of neutrophils into the alveolar airspace [75].
Using modern methods, these observations have been
confirmed [22]. There is clear evidence that fibrin deposition
and microvascular thrombosis are early events in the develop-
ment of ALI/ARDS, although the mechanisms remain unclear.
Several attempts were made to regulate the crosstalk
between coagulation and inflammation in clinical trials.
Although not focused on the treatment of ARDS, human
recombinant protein C has been shown to increase survival in
patients with severe sepsis [76].
Because of its central role in triggering blood coagulation with
extensive consequences for both fibrin formation and
inflammatory response, the modulation of tissue factor (TF)-
dependent pathways has gained interest in animal and human
studies. TF is the cellular transmembrane receptor for factor
VIIa. It is expressed by circulating monocytes and, at least
under inflammatory conditions, by endothelial cells. In the lung,
TF is expressed by alveolar macrophages and alveolar
epithelial cells [77]. During inflammation, TF expression and
activity are increased in lung, brain, and kidney [78]. Beyond
its importance for hemostasis and thrombosis, TF has direct
and indirect effects on the inflammatory system, mainly via
production of thrombin, which activates proteinase activated
receptor-1 to -4 and cleaves fibrinogen [79]. Activated by the
binding of factor VIIa, TF induces the expression of several
proinflammatory genes (e.g. IL-1β, IL-6, IL-8) [80] that may be
involved in the development of ARDS [81]. TF levels in
patients with ARDS are correlated with lung injury score,
suggesting that blocking TF-dependent inflammation might be
promising for the development of new therapeutic strategies.
TF pathway inhibitor (TFPI)-1 is an endogenous inhibitor of
the TF–factor VIIa complex. However, its physiological role in
controlling excessive TF-induced coagulation and
inflammation in the clinical setting of sepsis and lung injury
might be limited [82]. Although treatment with recombinant
TFPI-1 in animal models of lung injury was promising, it failed
to improve survival of patients with severe sepsis in a phase
III clinical trial [83]. TFPI-1 does not affect the internalization
of factor VIIa, which is pivotal for further TF-dependent
signaling [84], and requires factor Xa for the formation of the
inhibitory quaternary complex [85]. Therefore, TFPI-1
strategies might be less effective than blocking TF and/or
factor VIIa directly. Blocking TF might interrupt a self-
amplifying loop in which further signaling promotes
inflammation [86]. Experimental findings showed that
inhibition of the TF–factor VIIa complex increased survival in
endotoxin-induced sepsis and ALI [87,88], even in a state of
established sepsis [89].
Conclusion
Patients with ALI still have a poor prognosis in terms of
survival and long-term morbidity. The decrease in ARDS-
related mortality is mainly based on improvement in
supportive therapies such as protective ventilatory strategies
[45]. Other supportive approaches such as restrictive fluid
management are currently being investigated. Despite great
effort, our understanding of the molecular and cellular
mechanisms of ALI and ARDS were recently found to be
‘embryonic at best’ [90].
The excessive activation and migration of circulating
neutrophils from blood to the alveolar airspace is one of the
key events in the early development of ALI. Blocking Mac-1,
ICAM-1, or combinations of adhesion molecules has been
shown to protect against lung injury in many experimental
studies. In animal models, reliable methodologic approaches
to assess PMN recruitment in the lung can elucidate the
different mechanisms of PMN trafficking in the intravascular,
interstitial, and alveolar compartments. However, the clinical
relevance of these animal models remains unclear, and
translation into clinical studies is difficult. These limitations
include the absence of comorbidity, mechanical ventilation,
fluid management, antibiotic treatment, nutrition, and other
factors that may have an impact on outcome in humans. In
addition, classical ARDS criteria are usually not tested in
animal models. Therefore, clinical studies are required to
obtain definitive answers [90].
Finally, neutrophil recruitment into the lung is essential for
host defense against bacterial infections [91,92]. The dual
role of neutrophils in the lung – defending against infection
and mediating lung injury – is not well understood, but must
be considered in evaluation of therapeutic approaches.
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